2020 ASCO Virtual Direct™ Highlights

 

Skin
12:19

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Highlights on Melanoma: How Effective Is the Combination of CTLA4 + PD-1 After Progression on PD-1 & Do We Need More Than 2 Doses? Is There a Long-Term Benefit of Adjuvant Dab + Tram in Resected Stage III BRAF V600E/K Melanoma?

FEATURING Marlana Orloff
  • 85 views
  • August 20, 2020
08:06

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Resectable Stage III Melanoma: Can We Avoid TLND With Neoadjuvant Ipilimumab + Nivolumab?

FEATURING Marlana Orloff
  • 54 views
  • August 20, 2020
04:41

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Follow Up on Advanced Melanoma: Should We Consider TIL as 2L / 3L Treatment Options?

FEATURING Marlana Orloff
  • 41 views
  • August 13, 2020
13:04

2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Metastatic Melanoma: Is Toripalimab + Axitinib a Promising Treatment Regimen for Mucosal Melanoma? Is Concurrent IT / IV Nivo Safe and Well-Tolerated in Patients w/ Leptomeningeal Disease?

FEATURING Marlana Orloff
  • 21 views
  • August 20, 2020